Biomarin Pharmaceutical
Price & Volume
Stats
See more52W Range | $49.26-$70.98 |
Market Cap | $12.5B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $3.4B |
Revenue Growth (YoY) | 19.9% |
Gross Profit (12 Mos) | $1.7B |
Diluted EPS | $0.36 |
News
See moreYahoo Finance • 7 days ago
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
Yahoo Finance • 8 days ago
BioMarin acquiring Alesta Therapeutics for $275 million
Yahoo Finance • 9 days ago
BioMarin Pharmaceutical's Alesta Deal Strengthens Long-Term Growth Outlook, Wedbush Says
Yahoo Finance • 10 days ago
Does BioMarin’s Raised 2026 Outlook and ESOP Shelf Offering Reshape the Bull Case for BMRN?
About
CEO | Mr. Alexander Hardy |
CFO | Mr. Brian R. Mueller CPA |
Address | 770 Lindaro Street, San Rafael, CA, United States, 94901 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3,221 |